Task: Answer the multiple choice question.
Question: Which drug exhibits a 4.759\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) Cc1ccc(C)n1-c1ncc(Br)cn1
(b) Cc1ccc(S(=O)(=O)N2CCC3(CC2)OCCN3S(=O)(=O)c2c(C)cc(C)cc2C)cc1
(c) COc1cccc(CNC(=O)CCC2CCCN(C3CCOCC3)C2)c1
(d) O=C(CCCn1c(=S)[nH]c2cc3c(cc2c1=O)OCO3)N1CCN(c2ccccc2)CC1
(e) CCCCN(CCCC)C(=O)CCS(=O)(=O)c1ccc2c(c1)n(C)c(=O)c(=O)n2C
Answer: c. COc1cccc(CNC(=O)CCC2CCCN(C3CCOCC3)C2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(CNC(=O)CCC2CCCN(C3CCOCC3)C2)c1
COc1cccc(CNC(=O)CCC2CCCN(C3CCOCC3)C2)c1
N-[(3-methoxyphenyl)methyl]-3-[1-(oxan-4-yl)piperidin-3-yl]propanamide